Benjamin Hohl

Chief Financial Officer, Enliven Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$1.8M

Companies

Latest trade

Oct 19, 2026

Companies

Enliven Therapeutics, Inc.Chief Financial Officer −$1.8M

Trades

ELVN Sold 6,018 shares at $38.48 · planned $0.2M Oct 19

ELVN Sold 6,018 shares at $50.35 · planned $0.3M Sep 17

ELVN Sold 6,018 shares at $58.58 · planned $0.4M Aug 17

ELVN Sold 6,018 shares at $52.64 · planned $0.3M Jul 17

ELVN Sold 6,018 shares at $43.80 · planned $0.3M Jun 17

ELVN Sold 10,000 shares at $29.58 $0.3M Mar 6

ELVN Sold 3,250 shares at $20.40 · planned $0.1M Sep 29

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.